Seegene Unveils Groundbreaking PCR Automation System
Seegene Inc., a pioneer in the realm of molecular diagnostics, has taken a bold step forward in the world of diagnostics by introducing its fully automated PCR testing system known as CURECA™. This cutting-edge technology aims to reshape the landscape of laboratory testing, drastically enhancing efficiency and accuracy.
Introducing CURECA™: A New Dawn in Automation
CURECA™ is presented as the world's first system capable of completely automating the entire PCR testing process—from sample collection and treatment through to nucleic acid extraction and analysis. This remarkable innovation ensures 24/7 uninterrupted operation, significantly minimizing human error while providing consistent and reliable test outcomes.
Key Features of CURECA™
One of CURECA™'s standout developments is its fully automated prep module. This module addresses a common pain point in laboratory workflows: the cumbersome and error-prone pre-treatment phase. Historically, technicians have faced challenges with diverse sample types such as blood, urine, sputum, and stool, when conducting manual processes over extensive hours. The new prep module automates the entire pre-treatment process across all major sample types, including notoriously difficult stool samples.
Benefits of Automation
By automating the prep stage, CURECA™ reduces the labor burden on staff and increases sample throughput. It also pivots laboratory technicians into more analytical roles, focusing on data interpretation rather than repetitive tasks. This approach not only maximizes operational efficiency but also cultivates a higher quality of testing in continuous operation settings.
Expansive Applications Beyond PCR
The versatility of CURECA™ goes beyond just PCR diagnostics. The prep module is designed to accommodate pre-treatment for other functions, including clinical chemistry and immunoassays, indicating a significant leap in automation technology across the diagnostics sector. The modular design allows for tailoring to the specific needs and layouts of different laboratories, making it adaptable and innovative.
STAgora™: A Data Analytics Revolution in Healthcare
Alongside CURECA™, Seegene is also unveiling STAgora™, a cutting-edge statistical platform that compiles and interprets real-time PCR diagnostic data. This system is set to enhance clinical decision-making by providing integrated insights into infection trends and positivity rates across various healthcare institutions globally.
The Power of Real-Time Data
STAgora™ aggregates test data from hospitals worldwide, shattering barriers to real-time analysis and allowing healthcare providers to compare individual patient results with local epidemiological data. This comparison is pivotal for developing accurate, data-driven treatment strategies and improving overall patient care.
Empowering Healthcare Providers
Healthcare providers using STAgora™ can analyze infection trends not only at the individual patient level but also within the broader community. The availability of reliable data helps in refining diagnostics and care planning, positioning STAgora™ as an invaluable tool in clinical environments.
Building Strategic Partnerships for Global Reach
Seegene is committed to expanding access to its groundbreaking technologies, with plans for early pilot experiences and the cultivation of strategic partnerships worldwide. Following a successful unveiling at ADLM 2025, the company aims to broaden its influence in healthcare through collaboration and innovation.
This initiative aligns with Seegene's previous success at prominent conferences, showcasing CURECA™ and STAgora™. The launch of local subsidiaries in the U.S. is part of an ongoing effort to bolster research, development, and production capacity in North America, enhancing the company's global footprint.
Statements from Leadership
“CURECA™ and STAgora™ represent much more than mere instruments and software—they are the dawn of a new global standard in clinical diagnostics,” stated Daniel Shin, Executive Vice President and Chief of Global Sales & Marketing at Seegene. “We are dedicated to continuing our tradition of innovation and technological advancement to benefit the global diagnostics ecosystem.”
About Seegene
With over two decades of experienced leadership in R&D, manufacturing, and commercial development concerning syndromic real-time PCR technologies, Seegene's expertise blossomed notably during the COVID-19 pandemic, equipping over 100 countries with more than 340 million tests. This technology allows simultaneous testing for multiple pathogens, significantly enhancing diagnostic capabilities.
Frequently Asked Questions
What is CURECA™?
CURECA™ is Seegene's fully automated PCR testing system that optimizes laboratory testing processes by reducing human intervention.
How does STAgora™ support data analytics?
STAgora™ aggregates real-time PCR data from hospitals, enabling healthcare providers to make informed clinical decisions based on regional trends.
What are the applications of CURECA™ beyond PCR diagnostics?
CURECA™ is designed to also support clinical chemistry and immunoassays, providing flexibility across various laboratory needs.
What benefits do automated systems like CURECA™ offer?
This automation reduces labor-intensive tasks, increases testing efficiency, and enhances the reliability of laboratory results.
What is Seegene's commitment to global diagnostics?
Seegene aims to expand access to its technologies through pilot partnerships and strategic collaborations worldwide to redefine laboratory diagnostics.
